Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer

Harvey, VJ, Hardy, JR, Smith, S, Grove, W and Baguley, BC (1991) Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer. European Journal of Cancer, 27 12: 1617-1620. doi:10.1016/0277-5379(91)90427-F


Author Harvey, VJ
Hardy, JR
Smith, S
Grove, W
Baguley, BC
Title Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer
Journal name European Journal of Cancer   Check publisher's open access policy
ISSN 0959-8049
Publication date 1991-12
Sub-type Article (original research)
DOI 10.1016/0277-5379(91)90427-F
Volume 27
Issue 12
Start page 1617
End page 1620
Total pages 4
Language eng
Keyword Antitumor-Activity
Topoisomerase-II
Etoposide
Tumors
Trial
Mice
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 24 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 22 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 09 Jul 2012, 15:48:05 EST by System User